Course Overview

** The AODH CME activity has been discontinued as of September, 2017. However, quizzes are valid for one year following their publication date, so the July/August 2017 quiz will be the last to expire on July 1, 2018. ** 

This Continuing Medical Education (CME) activity involves reading a specific issue of Alcohol, Other Drugs, and Health: Current Evidence and completing a test that will assess your comprehension of the information presented in that issue. To successfully complete this CME activity, participants are required to read the entire newsletter, submit the online post-test within a designated period of time, and achieve a score of 70% or better.

At the end of the post-test, a certificate of completion is automatically generated* for those who achieve a score of 70% or better. The certificate is in PDF format; Adobe Acrobat is required to view, print, and/or save your certificate to your computer. To download the most recent version of Adobe Reader, click here.

*NOTE: You MUST either print or save the certificate to your computer immediately after taking the test. You cannot return and print your certificate at a later date. In some browsers, you will be prompted to save the file as an active server page (.asp). If this happens, save the file to your desktop, then right-click on the file and change the extension from .asp to .pdf.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Boston Medical Center. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians. Boston University School of Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

If you have questions or would like more information about the Boston University School of Medicine’s Department of Continuing Education, please visit www.bu.edu/cme.

Target Audience
The target audience is generalist clinicians, many of whom have received limited training on detecting and treating substance abuse.

Educational Needs Addressed
Primary-care clinicians often miss the diagnosis of alcohol or drug problems and cannot stay abreast of the current substance-abuse literature in the context of a busy practice. Because of the effects of alcohol and drugs on adherence to care plans and physician-patient relationships, patients with alcohol or drug problems may receive suboptimal treatment for other conditions. Further, physicians sometimes perceive alcohol or drug dependence as less treatable than other medical conditions, and thus delegate responsibilities for screening and intervention to others. At the root of the screening and treatment gap is the inadequate provision of substance-abuse education in medical schools and mental-health fields. The newsletter addresses this not only by research dissemination but by providing free downloadable teaching tools for use by educators.

Educational Objectives
At the conclusion of this program, participants will be able to state the latest research findings on alcohol, illicit drugs, and health; incorporate the latest research findings on alcohol, illicit drugs, and health into their clinical practices, when appropriate; and recognize the importance of addressing alcohol and drug problems in primary care settings. In sum, the purpose of the newsletter is to raise the status of alcohol and drug problems in both academic and clinical culture to promote evidence-based screening and treatment and ultimately improve patient care.

Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education/Continuing Education (CME/CE) activities to disclose all relationships with commercial interests. This information is disclosed to activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

 

Course Faculty
Richard Saitz, MD, MPH, DFASAM, FACP
Professor of Community Health Sciences and Medicine
Chair, Department of Community Health Sciences
Boston University Schools of Public Health & Medicine

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

David A. Fiellin, MD
Professor of Medicine
Section of General Internal Medicine
Yale University School of Medicine

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Nicolas Bertholet, MD, MSc
Center for Alcohol Treatment
Department of Medicine and Public Health
Lausanne University, Switzerland

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

R. Curtis Ellison, MD
Professor of Medicine and Public Health
Chief, Section of Preventive Medicine and Epidemiology
Evans Department of Medicine
Director, Institute on Lifestyle and Health
Boston University School of Medicine

Faculty member is the Director of the Institute on Lifestyle and Health, which receives various donations from individuals and companies in the alcohol beverage industry, given as “unrestricted educational gifts.” Funds are not given for specific research projects and donors have no prior information on, or input into, the surveillance being carried out or critiques published by the Institute or the Section. Faculty member does not discuss unlabeled/investigational uses of a commercial product.

Peter D. Friedmann, MD, MPH
Chief Research Officer
Baystate Health

Faculty member receives grant/research support from Alkermes, Inc. and is a stockholder in Becton-Dickenson, Pfizer, and Siemens. Faculty member does not discuss unlabeled/ investigational uses of a commercial product.

Kevin L. Kraemer, MD, MSc
Associate Professor of Medicine and Health Policy and Management
Director, General Internal Medicine Fellowship Program
Division of General Internal Medicine
University of Pittsburgh Schools of Medicine and Public Health

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Hillary Kunins, MD, MPH, MS
New York City Department of Health and Mental Hygiene and
Professor of Clinical Medicine, Psychiatry & Behavioral Sciences
Albert Einstein College of Medicine

Faculty member has nothing to disclose in regards to commercial support and does notdiscuss unlabeled/investigational uses of a commercial product.

Sharon Levy, MD
Director, Adolescent Substance Abuse Program
Boston Children’s Hospital
Associate Professor of Pediatrics
Harvard Medical School

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Joseph Merrill, MD
Associate Professor of Medicine
University of Washington School of Medicine

Faculty member has nothing to disclose in regards to commercial support and does (plan to) discuss unlabeled/investigational uses of a commercial product.

Seonaid Nolan, MD
Clinical Assistant Professor of Medicine
University of British Columbia

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Darius A. Rastegar, MD
Assistant Professor of Medicine
Johns Hopkins School of Medicine

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Jeffrey H. Samet, MD, MA, MPH
John Noble, M.D. Professor in General Internal Medicine and Professor of Community Health Sciences
Boston University Schools of Medicine and Public Health
Chief, Section of General Internal Medicine
Boston Medical Center

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Jeanette M. Tetrault, MD
Associate Professor of Internal Medicine
Yale University School of Medicine

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Alexander Y. Walley, MD, MSc
Associate Professor of Medicine
Boston Medical Center
Boston University School of Medicine

Faculty member has nothing to disclose in regards to commercial support and does not discuss unlabeled/investigational uses of a commercial product.

Katherine Calver, PhD
Managing Editor
Alcohol, Other Drugs, and Health: Current Evidence
Boston Medical Center

Staff member has nothing to disclose in regards to commercial support.

Jody Walker
Boston University School of Medicine CME Program Manager

Staff member has nothing to disclose in regards to commercial support.

Privacy Policy

The Office of Continuing Medical Education adheres to Boston University’s Conditions of Use and Policy on Computing Ethics. Data gathered from participants who participate in Boston University School of Medicine’s (BUSM) Continuing Medical Education Internet-Based CME program is confidential. Individual identifiable information is not shared with outside parties. Cumulative data may be analyzed by CME personnel, and upon occasion, by individuals external to BUSM CME, in order to determine trends.

To review the privacy policy of Alcohol, Other Drugs, and Health: Current Evidence, click here.

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. TRUSTEES OF BOSTON UNIVERSITY MAKES NO WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL TRUSTEES OF BOSTON UNIVERSITY BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Financial Support
This activity is funded by grant no. R25-DA013582 from the National Institute on Drug Abuse (NIDA). The content is solely the responsibility of the authors and does not necessarily represent the official views of NIDA or the National Institutes of Health.

Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.

© Trustees of Boston University 2017.